EPG Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
EPG Wealth Management's XBI Position: Q1 2026 in Review
EPG Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.3% in Q1 2026, selling an estimated $1.37K and leaving 811 shares worth $104K. The position accounts for 0.03% of the portfolio, ranked #205.
EPG Wealth Management first reported a position in XBI in Q4 2019 and has held it in 15 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- EPG Wealth Management held 811 shares of State Street SPDR S&P Biotech ETF worth $104K as of Q1 2026.
- EPG Wealth Management sold 11 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.37K.
- State Street SPDR S&P Biotech ETF made up 0.03% of EPG Wealth Management's portfolio in Q1 2026, its #205 holding.
- EPG Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 15 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.